Peer Review History
| Original SubmissionNovember 9, 2021 |
|---|
|
PONE-D-21-35409The effects of exercise on body composition of prostate cancer patients receiving androgen deprivation therapy: an update systematic review and meta-analysisPLOS ONE Dear Dr. Zhang, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. The revision requests for this particular manuscript is acknowledge to be significant but it is believed that if the authors are able to meet these revision requests, it will significantly improve this manuscript. Please submit your revised manuscript by Feb 02 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Henry Woo Academic Editor PLOS ONE Journal Requirements: Journal requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Partly ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: I Don't Know Reviewer #2: No ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: The selection of trials appears to be apprioriate. The conclusions appear reasonable. A few comments 1. Some of the text refers to the fact that ADT causes a decline in bone mineral density and exercise may "ameliorate" that but I would expect more of a focus in the results and discussion about "lack of decline" in BMD rather than an "improvement" I could not see that this was addressed in the manuscript. This sentence in the results could be modified "Relative to the control group, the exercise intervention was not associated with significant improvements in the whole-body BMD". This led me to think that the investigators were searching for an improvement... rather than lack of a decline... 2. In general I would prefer a change in some of the language used throughout the manuscript. particularly in relation to the use of the term "pca patients". I think it is best to switch that term around, remove the "pca" abbreviation. Focus on the patient and use the term "patients with prostate cancer" instead. In addition I feel that we have moved on from using the word "elderly" in publications now in preference to the term "older" and "older adults" with prostate cancer. A minor point perhaps but I feel that the language matters in such publications. 3. Please help the reader and define RM somewhere to enable enhanced understanding when terms like "8-12RM" are used. 4. What does "starting exercise after ADT" mean? Is that with the ADT? Is that before short term ADT is completed? Can this be clarified in the text please? This line in the conclusion could also be clarified "The best time to start exercise is immediately after ADT" 5.Meta analyses using individual patient data can yield more robust results. I imagine this analysis is not suited to technique that given the heterogeneity of the interventions? 6. What is a guarantor? 7. What is the meaning of this sentence in the discussion "It is difficult to explore the probably reasons for the significant differences, but a lower exercise intensity (8-12 RM) will be better, considering the effect of exercise and the age and physical condition of Pca patients"? 8. And the next sentence needs rewording too "while several evidences suggested" Page 20 line 294 Reviewer #2: I commend the authors for their efforts to put this comprehensive SRMA in prostate cancer, including a range of body composition components following exercise in this population. However, I do not think this study is up-to-date or brings novelty to this population. Although the authors justify their study by saying that “Three reviews have described conflicting findings regarding the effects of exercise for PCa patients who were treated using ADT”, several SRMAs were recently published. The angle proposed by the authors is not expanding knowledge on the topic. Please, find three recent SRMA that have investigated body composition: Bigaran et al. The effect of exercise training on cardiometabolic health in men with prostate cancer receiving androgen deprivation therapy: a systematic review and meta-analysis. Prostate Cancer Prostatic Dis. 2021 Mar;24(1):35-48. doi: 10.1038/s41391-020-00273-5. Epub 2020 Aug 28. PMID: 32860010. Lopez et al. Resistance Exercise Dosage in Men with Prostate Cancer: Systematic Review, Meta-analysis, and Meta-regression. Med Sci Sports Exerc. 2021 Mar 1;53(3):459-469. doi: 10.1249/MSS.0000000000002503. PMID: 32890199; PMCID: PMC7886340. Lopez et al. Interventions for improving body composition in men with prostate cancer: A systematic review and network meta-analysis. Med Sci Sports Exerc. Published Ahead-of-Print. Additionally, the meta-analysis model utilised is another critical issue. First, a fixed-effect model is not feasible in this setting, even with low heterogeneity. A random-effects model is highly recommended because of the high variability in this setting such as population characteristics, exercise modalities utilised, and outcomes. Second, several issues were identified in data extraction, such as the number utilised for meta-analyses and those reported within studies. Find a table below concerning the results on lean body mass: Reported Shao et al., 2021 Study Mean difference 95% CI Mean difference 95% CI Alberga et al., 2012 2.76 0.87 to 4.65 2.76 0.97 to 4.55 Cormie et al., 2015 0.7 -0.1 to 1.6 0.90 0.11 to 1.69 Galvao et al., 2010 0.8 0.0 to 1.5 0.70 -3.30 to 4.70 Lam et al., 2020 Not reported Not reported 1.00 -4.80 to 6.80 Ndjavera et al., 2020 1.2 -1.2 to 3.7 1.60 -2.03 to 5.23 Newton et al., 2019 0.5 0.5 -3.6 to 4.6 -4.0 to 5.0 0.50 -2.37 to 3.37 Nilsen et al., 2015 0.5 -0.2 to 1.2 0.60 -0.12 to 1.32 Taaffe et al., 2018 0.3 -0.3 to 0.8 0.23 -3.09 to 3.55 Taaffe et al., 2019 0.8 -3.5 to 5.1 0.80 -2.26 to 3.86 This issue was also observed in the other outcomes investigated by the authors. Key concerns:- 1) the rationale for the study is missing key points and is not considering the most up-to-date literature, and 2) issues were identified in data extraction and affected meta-analysis results. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: Yes: Christopher Steer Reviewer #2: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
The effects of exercise on body composition of prostate cancer patients receiving androgen deprivation therapy: an update systematic review and meta-analysis PONE-D-21-35409R1 Dear Dr. Zhang, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Henry Woo Academic Editor PLOS ONE |
| Formally Accepted |
|
PONE-D-21-35409R1 The effects of exercise on body composition of prostate cancer patients receiving androgen deprivation therapy: an update systematic review and meta-analysis Dear Dr. Zhang: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Prof. Henry Woo Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .